88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Department of Health - Abu Dhabi and Fred Hutchinson Cancer Center collaborate on cancer research and personalized prevention ABU DHABI, UAE , May 13, 2026 /PRNewswire/ -- The Department of Health - Abu Dhabi (DoH), regulator of the healthcare sector in the emirate, together with the Abu Dhabi Public Health Center (ADPHC), ... 2026-05-13T Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
High-Trend International Group Announces Pricing of $15 Million Registered Direct Offering with Global Institutional Investors NEW YORK , May 13, 2026 /PRNewswire/ -- High-Trend International Group (NASDAQ: HTCO) (" HTCO " or the " Company "), a global ocean transportation company, today announced that it ... 2026-05-13T Banking/Financial Service Computer/Electronics Maritime/Shipbuilding Medical/Pharmaceuticals
Getting a leg up on diabetic lower limb amputation with new AI risk prediction model SINGAPORE , May 13, 2026 /PRNewswire/ -- Personalised risk-based monitoring may soon be the norm for patients with diabetes at high risk of lower extremity amputation (LEA). Jointly developed by ... 2026-05-13T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
THE ADECCO GROUP Q1 2026 RESULTS Strong revenue growth, share gains and improved profitability, supported by rigorous execution ... 2026-05-13T Banking/Financial Service Computer Software Computer/Electronics Medical/Pharmaceuticals
New Nature Communications Publication Highlights Efsubaglutide Alfa's Effects on Glycaemia and β-Cell Function HONG KONG , May 13, 2026 /PRNewswire/ -- A major new clinical study, SUPER 2, has been published in Nature Communications , reporting that Efsubaglutide Alfa, a long-acting GLP-1 receptor agonist, ... 2026-05-13T Health Care/Hospital Medical/Pharmaceuticals
WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index SHANGHAI , May 13, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that, in recognition of its continued ... 2026-05-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innovent to Present Multiple Clinical and Preclinical Results of Mazdutide and Next-Generation Obesity & Metabolic Pipeline at the 2026 ADA Scientific Sessions SAN FRANCISCO and SUZHOU, China , May 13, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ... 2026-05-13T Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody CHENGDU, China , May 12, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that it has received a clinical ... 2026-05-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GenScript Launches TurboCHO™ Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class New kit offers researchers and development teams a meaningful advance in expression speed and output ... 2026-05-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Porton Advanced and Dark Horse Consulting Group Announce Memorandum of Understanding Providing A Streamlined Path to Conducting IITs in China CRANBURY, N.J. and SUZHOU, China , May 12, 2026 /PRNewswire/ -- Porton Advanced, a premier contract development and manufacturing organization (CDMO) specializing in Advanced Therapy Medicinal Products ... 2026-05-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals